Skip to content
healthcare.dev

Guaifenesin

NDC 71679-309, Guaifenesin, tablet, from Health Pharma USA LLC.

Product NDC
71679-309
Status
Listed
Labeler
Health Pharma USA LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71679-309 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN400 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
71679-309-007167903090038500 TABLET in 1 BOTTLE (71679-309-00)
71679-309-0271679030902200 TABLET in 1 BOTTLE (71679-309-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 71679-309 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71679-309 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71679-309. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.